Management of Cheyne-Stokes Respiration in Neurological Conditions
In patients with Cheyne-Stokes respiration (CSR) due to neurological conditions, particularly acute stroke, provide supplemental oxygen to maintain oxygen saturation ≥92-95% and position the patient with head of bed elevated 15-30° if there is risk of airway compromise or elevated intracranial pressure. 1, 2
Immediate Assessment and Monitoring
- Monitor oxygen saturation continuously with pulse oximetry, targeting SpO2 ≥92-95% in stroke patients with CSR 1, 2
- Recognize that CSR occurs frequently after stroke (particularly with bilateral hemispheric involvement, large-artery atherosclerosis, or cardioembolic stroke) and causes oxygen desaturation that can worsen neurological injury 1, 3
- Administer supplemental oxygen when hypoxia is documented by pulse oximetry or blood gas determination, as CSR-related desaturations can be readily reversed with oxygen supplementation 1, 4, 2
Patient Positioning Strategy
- For nonhypoxic patients who can tolerate lying flat, use supine position to optimize cerebral perfusion 1
- Elevate head of bed 15-30° in patients with:
- Monitor airway, oxygenation, and neurological status closely when changing patient position, adjusting as clinical parameters change 1
Airway Management Considerations
- Consider endotracheal intubation if the airway is threatened, particularly in patients with decreased consciousness or brain stem stroke who have impaired oropharyngeal mobility and loss of protective reflexes 1, 4, 2
- Note that approximately 50% of stroke patients requiring intubation die within 30 days, but airway protection prevents aspiration pneumonia—a leading cause of post-stroke death 4, 2
- Elective intubation may be necessary for patients with severely increased intracranial pressure or malignant brain edema 4, 2
Oxygen Therapy Specifics
- Do not routinely administer supplemental oxygen at 3 L/min to all stroke patients, as controlled trials show no benefit in normoxic patients 4, 2
- Provide oxygen only when indicated by:
- High-flow normobaric oxygen started within 12 hours may provide transient neurological improvement, though evidence is limited 1
- Avoid hyperbaric oxygen therapy, as data show no benefit and potential harm in acute ischemic stroke 2
Medications to Avoid
- Avoid sedative medications and central nervous system depressants as they worsen hypoventilation and can further depress respiratory drive in patients with CSR 5
- This includes opiates, benzodiazepines, and other agents that depress upper airway tone 6
Treatment of Underlying Cardiac Dysfunction
- If CSR is associated with congestive heart failure (common comorbidity), optimize cardiac function medically as this may improve breathing abnormalities 6, 7, 8
- Note that low left ventricular ejection fraction and left atrial enlargement are associated with CSR in acute stroke 3
- CPAP is not recommended as first-line treatment for CSR in heart failure patients, as randomized trials suggest increased mortality in the first 2 years 6
Common Pitfalls
- Do not delay stroke treatment to address CSR—manage oxygenation and ventilation while proceeding with acute stroke protocols 1
- Recognize that CSR indicates severe neurological disorder and is associated with worse outcomes, particularly with bilateral hemispheric involvement 9, 3
- CSR may not be immediately recognized as clinical features are often dominated by the underlying stroke 7
- Continuous monitoring is essential because patients with CSR may experience profound hypoxemia before physiologic compromise is clinically detected 5
Long-term Ventilatory Support
- For patients with chronic neurological conditions requiring ongoing ventilatory support (e.g., neuromuscular disorders), positive pressure ventilation via tracheostomy is preferred over noninvasive ventilation to ensure optimal oxygenation 5
- Tracheostomy may be indicated for prolonged weaning from mechanical ventilation in acquired, potentially reversible neuromuscular disorders 10
- Do not perform tracheostomy in the acute setting with intracranial hypertension (ICP >15 mmHg) or severe hypoxemia (PaO2/FiO2 <100 mmHg) 10